These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10854046)

  • 1. How can hypertensive patients be better treated? The contribution of combination therapy.
    Benetos A; Guize L; Rudnichi A; Safar M; Asmar R; Bean K
    J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S13-16. PubMed ID: 10854046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
    Ruilope LM; de la Sierra A; Moreno E; Fernández R; Garrido J; de la Figuera M; de la Cámara AG; Coca A; Luque-Otero M
    J Hypertens; 1999 Dec; 17(12 Pt 2):1917-23. PubMed ID: 10703890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
    García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
    Muijsers RB; Curran MP; Perry CM
    Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
    Ruilope LM; Usan L; Segura J; Bakris GL
    J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group.
    Holzgreve H; Compagnone D; Zilles P
    J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
    Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fixed combination of verapamil SR/trandolapril.
    Widimský J
    Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination.
    Oren S; Viskoper JR; Zilles P
    Int J Cardiol; 1996 Jul; 55(1):97-102. PubMed ID: 8839816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.
    Atalar E; Eskin F; Tugtekin HB; Karabulut A; Kanyilmaz S; Kirbiyik H; Ozyildiz AG
    Biomed Res Int; 2020; 2020():2123601. PubMed ID: 32964020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group.
    DeQuattro V; Lee D
    Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
    Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM
    J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
    Messerli F; Frishman WH; Elliott WJ
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists.
    Karlberg BE; Andrup M; Odén A
    Blood Press; 2000; 9(2-3):140-5. PubMed ID: 10855738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trandolapril/verapamil combination in hypertensive diabetic patients.
    García Donaire JA; Ruilope LM
    Vasc Health Risk Manag; 2007; 3(1):77-82. PubMed ID: 17583177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.